Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ: DXCM )

79.86 +2.10 (+2.70%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... 
Via Benzinga
Pool, Dexcom Lead Five Stocks Showing Tight, Bullish Action Near Buy Points
Tight trading is a bullish sign. Pool, Dexcom lead five stocks trading tightly near buy points. 
Via Investor's Business Daily
DexCom And O'Reilly Auto Parts Lead The QQQ Monday
U.S. indices bounced off Monday morning’s lows as investors weigh weak China retail and production data. Uncertainty around the COVID-19 Delta variant is also weighing on... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Expert Ratings for DexCom
Analysts have provided the following ratings for DexCom (NASDAQ:DXCM) with... 
Via Benzinga
Where DexCom Stands With Analysts
DexCom (NASDAQ:DXCM) has observed the following analyst ratings within the... 
Via Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Unusual Options Activity Insight: DexCom
n Shares of DexCom (NASDAQ:DXCM) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $494.82. Sentiment: BULLISH Option... 
Via Benzinga
3 Growth Stocks to Buy and Hold Regardless of What Happens With the Delta Variant
These companies are still going to be great long-term buys. 
Via The Motley Fool
Topics Economy
Exposures COVID-19 Economy
Analyzing DexCom's Unusual Options Activity
Shares of DexCom (NASDAQ:DXCM) saw some unusual options a... 
Via Benzinga
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 167 companies set new 52-week highs. Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by market cap to set a new... 
Via Benzinga
2 Top Growth Stocks That Could Help Your Portfolio Shine
These two stocks have been moving in opposite directions of late. 
Via The Motley Fool
63 Biggest Movers From Friday
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the... 
Via Benzinga
Exposures Product Safety
3 Stocks to Buy That Should Get a Boost From Pandemic-Driven Consumer Weight Gain
Athletic-apparel maker Lululemon and two diabetes specialists are poised to get a long-term tailwind from the COVID-19 pandemic. 
Via The Motley Fool
Exposures COVID-19
Dexcom Stock Jumps As Q2 Earnings Beats Street, Raises Guidance; Analysts Bump Up Target Price
Continuous glucose monitor developer Dexcom Inc (NASDAQ: DXCM) shares ticked up as second-quarter results easily topped the consensus forecast; adjusted EPS of... 
Via Benzinga
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Erytech Pharma (NASDAQ:ERYP) sha... 
Via Benzinga
Why Shares of Dexcom Are Gaining This Morning
Wall Street is thrilled with acceleration out of the pandemic and a new product on the horizon. 
Via The Motley Fool
10 Biggest Price Target Changes For Friday
Mizuho lowered the price target for Amazon.com, Inc. (NASDAQ: AMZN) from $4400 to $4100. Amazon shares fell 6.5% to $3,364.80 in pre-market trading. Cowen & Co. raised Yum... 
Via Benzinga
Stock Market Rally Pauses Near Highs Amid Earnings From Apple, Microsoft, Tesla, Amazon, Google, Facebook
The market rally paused on the key indexes amid earnings from Apple, Tesla and Amazon. But several stocks flashed buy signals. 
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
DexCom Inc (DXCM) Q2 2021 Earnings Call Transcript
DXCM earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
12 Stocks Moving In Thursday's After-Hours Session
Gainers Atlassian (NASDAQ: TEAM) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued Q1 EPS and sales guidance above... 
Via Benzinga
Why DexCom's Stock Is Trading Higher Today
DexCom, Inc. (NASDAQ: DXCM) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued FY21 sales guidance above estimates.... 
Via Benzinga
Recap: DexCom Q2 Earnings
Shares of DexCom (NASDAQ:DXCM) rose 3.7% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 3.80% year over year to $0.... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Erytech Pharma (NASDAQ:ERYP) sha... 
Via Benzinga
Dexcom Reports Second Quarter 2021 Financial Results
From DexCom, Inc.
Via Business Wire
FDA Clears Dexcom Real-Time APIs for Third-Party Apps and Devices
From DexCom, Inc.
Via Business Wire
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... 
Via Benzinga
Exposures Product Safety
Dexcom Schedules Second Quarter 2021 Earnings Release and Conference Call for July 29, 2021 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.